Decheng Capital China Life Sciences USD Fund I, L.P. — Form D/A
Decheng Capital China Life Sciences USD Fund I, L.P. of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2013-06-05. The offering totals $125.0M, of which $123.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2013-06-05
- Form: D/A
- Accession: 0001537339-13-000001
- Industry: Pooled Investment Fund
- Exemptions: 06, 3C, 3C.7
- Total offering: $125.0M
- Amount sold: $123.0M
- Remaining: $2.0M
- Investors: 17
- Date of first sale: 2011-12-15
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-170136
Issuer
- Name: Decheng Capital China Life Sciences USD Fund I, L.P.
- CIK: 0001537339
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2011
- Address: C/O MAPLES CORPORATE SERVICES LIMITED, GRAND CAYMAN, E9, KY1-1104
- Phone: (345) 949-8066
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| N/A NA Bay City Capital LLC | Director | Grand Cayman, E9 |
| Xiangmin NA Cui | Director | Grand Cayman, E9 |
| N/A NA DT Capital Management Company Limited | Director | Grand Cayman, E9 |
| N/A NA Bay City Capital LLC | Promoter | Grand Cayman, E9 |
| Xiangmin NA Cui | Promoter | Grand Cayman, E9 |
| N/A NA Decheng Capital China Management I (Cayman), LLC | Promoter | Grand Cayman, E9 |
| N/A NA DT Capital Management Company Limited | Promoter | Grand Cayman, E9 |
| Xiangmin NA Min | Director | Grand Cayman, E9 |
| Xiangmin NA Min | Promoter | Grand Cayman, E9 |
Other filings by this issuer (1)
More